The GEMA model was developed to eliminate gender disparities in access to liver transplantation. In a study of nearly 10,000 patients on the liver transplant waiting list in the UK and Australia, the GEMA model, which replaces serum creatinine with a glomerular filtration rate estimation formula specifically designed for patients with liver disease, has been trained and externally validated.
This substitution allows GEMA to correct for gender disparities in access to transplantation, and also makes much more accurate predictions of what will happen to a patient while on the waiting list. The GEMA study, published in the prestigious journal The Lancet Gastroenterology & Hepatology, opens the door to modifying the waiting list prioritisation system that has been in place for the past two decades.
From the following link you can read the news published in the Centro de Investigación Biomédica en Red.